» Articles » PMID: 20975040

Mouse CD8alpha+ DCs and Human BDCA3+ DCs Are Major Producers of IFN-lambda in Response to Poly IC

Abstract

Polyinosinic:polycytidylic acid (poly IC), a double-stranded RNA, is an effective adjuvant in vivo. IFN-λs (also termed IL-28/29) are potent immunomodulatory and antiviral cytokines. We demonstrate that poly IC injection in vivo induces large amounts of IFN-λ, which depended on hematopoietic cells and the presence of TLR3 (Toll-like receptor 3), IRF3 (IFN regulatory factor 3), IRF7, IFN-I receptor, Fms-related tyrosine kinase 3 ligand (FL), and IRF8 but not on MyD88 (myeloid differentiation factor 88), Rig-like helicases, or lymphocytes. Upon poly IC injection in vivo, the IFN-λ production by splenocytes segregated with cells phenotypically resembling CD8α(+) conventional dendritic cells (DCs [cDCs]). In vitro experiments revealed that CD8α(+) cDCs were the major producers of IFN-λ in response to poly IC, whereas both CD8α(+) cDCs and plasmacytoid DCs produced large amounts of IFN-λ in response to HSV-1 or parapoxvirus. The nature of the stimulus and the cytokine milieu determined whether CD8α(+) cDCs produced IFN-λ or IL-12p70. Human DCs expressing BDCA3 (CD141), which is considered to be the human counterpart of murine CD8α(+) DCs, also produced large amounts of IFN-λ upon poly IC stimulation. Thus, IFN-λ production in response to poly IC is a novel function of mouse CD8α(+) cDCs and their human equivalents.

Citing Articles

Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors.

Colaco M, Cruz M, de Almeida L, Borges O Pharmaceutics. 2024; 16(10).

PMID: 39458637 PMC: 11510408. DOI: 10.3390/pharmaceutics16101308.


Trial watch: anticancer vaccination with dendritic cells.

Borges F, Laureano R, Vanmeerbeek I, Sprooten J, Demeulenaere O, Govaerts J Oncoimmunology. 2024; 13(1):2412876.

PMID: 39398476 PMC: 11469433. DOI: 10.1080/2162402X.2024.2412876.


Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses.

Wang B, Zhou B, Chen J, Sun X, Yang W, Yang T J Immunother Cancer. 2024; 12(4).

PMID: 38589249 PMC: 11015199. DOI: 10.1136/jitc-2023-007808.


Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.

Liu Y, Jin S, Zhang S, Xia T, Liao Y, Pan R Front Immunol. 2024; 15:1338096.

PMID: 38495892 PMC: 10940417. DOI: 10.3389/fimmu.2024.1338096.


Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines.

Palomares F, Pina A, Dakhaoui H, Leiva-Castro C, Munera-Rodriguez A, Cejudo-Guillen M Vaccines (Basel). 2024; 12(2).

PMID: 38400148 PMC: 10891551. DOI: 10.3390/vaccines12020165.


References
1.
Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G, Nasilowska K . Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol. 2008; 83(5):1181-93. DOI: 10.1189/jlb.0807525. View

2.
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate M . IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009; 41(10):1100-4. DOI: 10.1038/ng.447. View

3.
Mombaerts P, Iacomini J, Johnson R, Herrup K, Tonegawa S, Papaioannou V . RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992; 68(5):869-77. DOI: 10.1016/0092-8674(92)90030-g. View

4.
Robbins S, Walzer T, Dembele D, Thibault C, Defays A, Bessou G . Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008; 9(1):R17. PMC: 2395256. DOI: 10.1186/gb-2008-9-1-r17. View

5.
Ank N, Paludan S . Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors. 2009; 35(1):82-7. DOI: 10.1002/biof.19. View